MedPath

Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs

Completed
Conditions
Gastroenteropancreatic Neuroendocrine Tumors
Registration Number
NCT02630654
Lead Sponsor
Ipsen
Brief Summary

This exploratory study aims to evaluate the diagnostic, prognostic and response predictive value of a multi biomarker strategy in patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs) originating from the midgut or pancreas. Using a recently developed methodology enabling the evaluation of 92 concomitant cancer biomarkers will provide an interesting approach to solve this question (Lundberg et al 2011).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
404
Inclusion Criteria
  • Provision of written informed consent prior to any study related procedures.
  • Suspected of suffering from a metastatic midgut NET or Pancreatic non-functional NET (WHO grade 1 or 2, up to 10% Ki67).
  • Male or female aged 18 or older.
Exclusion Criteria
  • Previously treated for the NET disease with pharmaceutical treatment, Peptide Receptor Radionuclide Therapy (PRRT) or radiation therapy(surgery of primary tumour is accepted)
  • Has any mental condition rendering the subject unable to understand the nature, scope and possible consequences of the study, and/or evidence of an uncooperative attitude.
  • Suffering from a malignant disease or previously treated for a malignant disease within the last 6 months.
  • Suffering from a chronic inflammatory disease.
  • Suffering from a renal and/or liver disease.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of Participants With Progression Free SurvivalUp to 60 months
Secondary Outcome Measures
NameTimeMethod
Change in oncological biomarker levelsBaseline visit and follow-up visit [i.e. every 3 months during the first year, every 6 months for the remainder of the study] up to 60 months

Trial Locations

Locations (9)

North Estonia Medical Center

🇪🇪

Tallinn, Estonia

Pauls Stradins Clinical University Hospital

🇱🇻

Riga, Latvia

Riga East University Hospital

🇱🇻

Riga, Latvia

The Hospital of Lithuanian Health Science

🇱🇹

Kaunas, Lithuania

Klaipėda University Hospital

🇱🇹

Klaipėda, Lithuania

National Cancer Institute

🇱🇹

Vilnius, Lithuania

Vilnius University Hospital

🇱🇹

Vilnius, Lithuania

Karolinska Universitetssjukhuset Bröst - och Endokrinkirurgiska kliniken

🇸🇪

Stockholm, Sweden

Södersjukhuset

🇸🇪

Stockholm, Sweden

North Estonia Medical Center
🇪🇪Tallinn, Estonia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.